scholarly journals Cytolytic responses: cadherins put out the fire

2006 ◽  
Vol 203 (2) ◽  
pp. 261-264 ◽  
Author(s):  
Marco Colonna

Cytotoxic lymphocytes, such as natural killer (NK) cells and CD8+ T cells, provide an essential defense against intracellular pathogens and tumors. During target cell recognition, these cells receive both activating and inhibitory signals. The cell must evaluate these opposing signals and determine the appropriate response: activation or inhibition. Classically, inhibitory signals are mediated by receptors that recognize MHC class I molecules (1). But recent studies, including one in this issue, suggest that MHC class I-independent inhibitory signals can also result in inhibition of cytotoxic cells.

2002 ◽  
Vol 196 (6) ◽  
pp. 817-827 ◽  
Author(s):  
Joke M.M. den Haan ◽  
Michael J. Bevan

Murine splenic dendritic cells (DCs) can be divided into two subsets based on CD8α expression, but the specific role of each subset in stimulation of T cells is largely unknown. An important function of DCs is the ability to take up exogenous antigens and cross-present them in the context of major histocompatibility complex (MHC) class I molecules to CD8+ T cells. We previously demonstrated that, when cell-associated ovalbumin (OVA) is injected into mice, only the CD8+ DC subset cross-presents OVA in the context of MHC class I. In contrast to this selectivity with cell-associated antigen, we show here that both DC subsets isolated from mice injected with OVA/anti-OVA immune complexes (OVA-IC) cross-present OVA to CD8+ T cells. The use of immunoglobulin G Fc receptor (FcγR) common γ-chain–deficient mice revealed that the cross-presentation by CD8− DCs depended on the expression of γ-chain–containing activating FcγRs, whereas cross-presentation by CD8+ DCs was not reduced in γ-chain–deficient mice. These results suggest that although CD8+ DCs constitutively cross-present exogenous antigens in the context of MHC class I molecules, CD8− DCs only do so after activation, such as via ligation of FcγRs. Cross-presentation of immune complexes may play an important role in autoimmune diseases and the therapeutic effect of antitumor antibodies.


2004 ◽  
Vol 173 (6) ◽  
pp. 3773-3782 ◽  
Author(s):  
Nicolas Anfossi ◽  
Scott H. Robbins ◽  
Sophie Ugolini ◽  
Philippe Georgel ◽  
Kasper Hoebe ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (11) ◽  
pp. e0187314 ◽  
Author(s):  
Shalini Sethumadhavan ◽  
Murillo Silva ◽  
Phaethon Philbrook ◽  
Thao Nguyen ◽  
Stephen M. Hatfield ◽  
...  

2015 ◽  
Vol 6 ◽  
Author(s):  
Jing Huang ◽  
Tiffany Tsao ◽  
Min Zhang ◽  
Urvashi Rai ◽  
Moriya Tsuji ◽  
...  

BMC Cancer ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Meriem Hasmim ◽  
Cécile Badoual ◽  
Philippe Vielh ◽  
Françoise Drusch ◽  
Virginie Marty ◽  
...  

2017 ◽  
Vol 1 (20) ◽  
pp. 1773-1785 ◽  
Author(s):  
Anne Zufferey ◽  
Edwin R. Speck ◽  
Kellie R. Machlus ◽  
Rukhsana Aslam ◽  
Li Guo ◽  
...  

Key Points Megakaryocytes process and present endogenous/exogenous antigens on MHC class I molecules to activate CD8+ T cells. Megakaryocytes can transfer MHC class I molecules loaded with foreign antigen to proplatelets in vitro.


Sign in / Sign up

Export Citation Format

Share Document